Shilpa Medicare informs about updates

16 Jul 2025 Evaluate
Shilpa Medicare has informed that the company, Unit VI, Dabaspet, Bengaluru, Karnataka, India has received EIR with VAI (Voluntary Action Indicated) classification, from USFDA, for the GMP inspection which was conducted from October 24 – 30, 2024. This facility is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms - Oral Dissolving Films and Transdermal Systems. The Unit is already approved by EMA, Europe; MHRA, UK; SFDA, Saudi and TGA, Australia. This Unit is currently supplying Oral Film products to US and other markets. Transdermal products have been filed in the European market.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

284.40 -5.55 (-1.91%)
20-Jan-2026 11:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1653.90
Dr. Reddys Lab 1170.15
Cipla 1390.00
Zydus Lifesciences 879.85
Lupin 2165.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×